| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 98, 1473-1479, Copyright © 1990 by American College of Chest Physicians
ARTICLES |
M Levine, J Hirsh, J Weitz, M Cruickshank, J Neemeh, AG Turpie and M Gent
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Experiments in animals have demonstrated that recombinant tissue plasminogen activator (rt-PA) produces continuing thrombolysis after it is cleared from the circulation and that thrombolysis is both increased and accelerated, and bleeding is reduced when rt-PA is administered over a short period. In previous studies in patients with thrombotic disease, rt-PA has been shown to be an effective thrombolytic agent when administered by continuous infusion over a period between 90 minutes and 8 hours. To determine whether a short course regimen of rt- PA can achieve thrombolysis, a double-blind randomized trial has been conducted in which patients with objectively established acute symptomatic pulmonary embolism who were receiving heparin were allocated to either a 2-minute infusion of rt-PA at a dose of 0.6 mg/kg (33 patients) or saline placebo (25 patients). Perfusion lung scanning was used to assess the change in pulmonary perfusion at 24 hours and seven days post-study drug administration. Thirty-four percent of the rt-PA patients had a greater than 50 percent resolution in the perfusion defect at 24 hours compared to 12 percent of placebo patients (p = 0.026). At 24 hours, the mean relative improvement in the perfusion defect was 37.0 percent in rt-PA treated patients compared to 18.8 percent in the placebo group (p = 0.017). By day 7, no difference in lung scan resolution was detected between the groups. There were no major bleeds in either group nor were there any differences in transfusion requirements between groups. Minor bleeding occurred in 15 of the rt-PA patients mainly at angiogram-catheter insertion and venipuncture sites. These results suggest that a bolus regimen of rt-PA produces accelerated thrombolysis and provides an alternative and convenient approach to thrombolytic therapy in patients with pulmonary embolism.
This article has been cited by other articles:
|
|
 |
|
  T. Capstick and M. T. Henry Efficacy of thrombolytic agents in the treatment of pulmonary embolism Eur. Respir. J., November 1, 2005; 26(5): 864 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Thabut and D. Logeart Thrombolysis for Pulmonary Embolism in Patients With Right Ventricular Dysfunction: Con Arch Intern Med, October 24, 2005; 165(19): 2200 - 2203. [Full Text] [PDF]
|
|
|
|
 |
|
 H. R. Buller, G. Agnelli, R. D. Hull, T. M. Hyers, M. H. Prins, and G. E. Raskob Antithrombotic Therapy for Venous Thromboembolic Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 401S - 428S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wan, D. J. Quinlan, G. Agnelli, and J. W. Eikelboom Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism: A Meta-Analysis of the Randomized Controlled Trials Circulation, August 10, 2004; 110(6): 744 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Kreit The Impact of Right Ventricular Dysfunction on the Prognosis and Therapy of Normotensive Patients With Pulmonary Embolism Chest, April 1, 2004; 125(4): 1539 - 1545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kearon Natural History of Venous Thromboembolism Circulation, June 17, 2003; 107(90231): I-22 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Jones, J. A. Watts, J. P. Debelak, L. R. Thornton, J. G. Younger, and J. A. Kline Inhibition of prostaglandin synthesis during polystyrene microsphere-induced pulmonary embolism in the rat Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L1072 - L1081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kucher, C.M. Luder, T. Dornhofer, S. Windecker, B. Meier, and O.M. Hess Novel management strategy for patients with suspected pulmonary embolism Eur. Heart J., February 2, 2003; 24(4): 366 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kearon Diagnosis of pulmonary embolism Can. Med. Assoc. J., January 21, 2003; 168(2): 183 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Madani and S. W. Jamieson Pulmonary Thromboendarterectomy Card. Surg. Adult, January 1, 2003; 2(2003): 1205 - 1228. [Full Text]
|
|
|
|
|
|
J. E. Dalen The Uncertain Role of Thrombolytic Therapy in the Treatment of Pulmonary Embolism Arch Intern Med, December 9, 2002; 162(22): 2521 - 2523. [Full Text] [PDF]
|
|
|
|
|
|
G. Agnelli, C. Becattini, and T. Kirschstein Thrombolysis vs Heparin in the Treatment of Pulmonary Embolism: A Clinical Outcome-Based Meta-analysis Arch Intern Med, December 9, 2002; 162(22): 2537 - 2541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Thabut, D. Thabut, R. P. Myers, B. Bernard-Chabert, R. Marrash-Chahla, H. Mal, and M. Fournier Thrombolytic therapy of pulmonary embolism: A meta-analysis J. Am. Coll. Cardiol., November 6, 2002; 40(9): 1660 - 1667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Dalen Pulmonary Embolism: What Have We Learned Since Virchow?: Treatment and Prevention Chest, November 1, 2002; 122(5): 1801 - 1817. [Full Text] [PDF]
|
|
|
|
|
|
G. S. Ahearn, D. Hadjiliadis, J. A. Govert, and V. F. Tapson Massive Pulmonary Embolism During Pregnancy Successfully Treated With Recombinant Tissue Plasminogen Activator: A Case Report and Review of Treatment Options Arch Intern Med, June 10, 2002; 162(11): 1221 - 1227. [Full Text] [PDF]
|
|
|
|
|
|
K. E. Wood Major Pulmonary Embolism : Review of a Pathophysiologic Approach to the Golden Hour of Hemodynamically Significant Pulmonary Embolism Chest, March 1, 2002; 121(3): 877 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Z. Goldhaber Thrombolysis in Pulmonary Embolism: A Large-Scale Clinical Trial Is Overdue Circulation, December 11, 2001; 104(24): 2876 - 2878. [Full Text] [PDF]
|
|
|
|
|
|
E. Hamel, G. Pacouret, D. Vincentelli, J. F. Forissier, P. Peycher, J. M. Pottier, and B. Charbonnier Thrombolysis or Heparin Therapy in Massive Pulmonary Embolism With Right Ventricular Dilation : Results From a 128-Patient Monocenter Registry Chest, July 1, 2001; 120(1): 120 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Hyers, G. Agnelli, R. D. Hull, T. A. Morris, M. Samama, V. Tapson, and J. G. Weg Antithrombotic Therapy for Venous Thromboembolic Disease Chest, January 1, 2001; 119(1_suppl): 176S - 193S. [Full Text] [PDF]
|
|
|
|
 |
|
 M.D. Thomas, A. Chauhan, and R.S. More Pulmonary embolism--an update on thrombolytic therapy QJM, May 1, 2000; 93(5): 261 - 267. [Full Text] [PDF]
|
|
|
|
|
|
S. M. Arcasoy and J. W. Kreit Thrombolytic Therapy of Pulmonary Embolism: A Comprehensive Review of Current Evidence Chest, June 1, 1999; 115(6): 1695 - 1707. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
